These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 37773290)
1. Is tear proteome profile a predictor of developing uveitis in ANA-positive patients with oligoarticular juvenile idiopathic arthritis? Yılmaz Tuğan B; Sarıhan M; Kasap M; Akpınar G; Karabaş L; Şahin N; Yüksel N; Bayrak YE; Sönmez HE Graefes Arch Clin Exp Ophthalmol; 2024 Jan; 262(1):211-221. PubMed ID: 37773290 [TBL] [Abstract][Full Text] [Related]
2. Proteomic profiling of extracellular vesicles in synovial fluid and plasma from Oligoarticular Juvenile Idiopathic Arthritis patients reveals novel immunopathogenic biomarkers. Raggi F; Bartolucci M; Cangelosi D; Rossi C; Pelassa S; Trincianti C; Petretto A; Filocamo G; Civino A; Eva A; Ravelli A; Consolaro A; Bosco MC Front Immunol; 2023; 14():1134747. PubMed ID: 37205098 [TBL] [Abstract][Full Text] [Related]
3. Joint hypermobility and oligoarticular juvenile idiopathic arthritis: What relationship? Cecchin V; Sperotto F; Balzarin M; Vittadello F; Martini G; Zulian F J Paediatr Child Health; 2017 Apr; 53(4):374-377. PubMed ID: 28052441 [TBL] [Abstract][Full Text] [Related]
4. Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER. Sahin S; Acari C; Sonmez HE; Kilic FZ; Sag E; Dundar HA; Adrovic A; Demir S; Barut K; Bilginer Y; Sozeri B; Unsal E; Ozen S; Kasapcopur O Pediatr Rheumatol Online J; 2021 Aug; 19(1):134. PubMed ID: 34425847 [TBL] [Abstract][Full Text] [Related]
5. Identification of key biomarkers in RF-negative polyarticular and oligoarticular juvenile idiopathic arthritis by bioinformatic analysis. Liu Y; Tang X Pediatr Rheumatol Online J; 2023 Nov; 21(1):143. PubMed ID: 38001449 [TBL] [Abstract][Full Text] [Related]
6. Predictive value of selected biomarkers, polymorphisms, and clinical features for oligoarticular juvenile idiopathic arthritis-associated uveitis. Pelegrín L; Casaroli-Marano R; Antón J; García de Vicuña MC; Molina-Prat N; Ignacio Aróstegui J; Yagüe J; Ríos J; Adán A Ocul Immunol Inflamm; 2014 Jun; 22(3):208-12. PubMed ID: 24131380 [TBL] [Abstract][Full Text] [Related]
7. Identification of novel autoantigens as potential biomarkers in juvenile idiopathic arthritis associated uveitis. Arve-Butler S; Mossberg A; Kahn F; Najibi SM; Berthold E; Król P; Månsson B; Kahn R Front Pediatr; 2022; 10():1091308. PubMed ID: 36699287 [TBL] [Abstract][Full Text] [Related]
8. Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT). Ramanan AV; Guly CM; Keller SY; Schlichting DE; de Bono S; Liao R; Quartier P Trials; 2021 Oct; 22(1):689. PubMed ID: 34627340 [TBL] [Abstract][Full Text] [Related]
9. Prevalence and titres of antinuclear antibodies in juvenile idiopathic arthritis: A systematic review and meta-analysis. Storwick JA; Brett AC; Buhler K; Chin A; Schmeling H; Johnson NA; Fritzler MJ; Choi MY Autoimmun Rev; 2022 Jun; 21(6):103086. PubMed ID: 35398272 [TBL] [Abstract][Full Text] [Related]
10. S100 proteins, cytokines, and chemokines as tear biomarkers in children with juvenile idiopathic arthritis-associated uveitis. Angeles-Han ST; Utz VM; Thornton S; Schulert G; Rodriguez-Smith J; Kauffman A; Sproles A; Mwase N; Hennard T; Grom A; Altaye M; Holland GN Ocul Immunol Inflamm; 2021; 29(7-8):1616-1620. PubMed ID: 35169380 [TBL] [Abstract][Full Text] [Related]
11. Uveitis and anti nuclear antibody positivity in children with juvenile idiopathic arthritis. Kasapçopur O; Yologlu N; Ozyazgan Y; Ercan G; Caliskan S; Sever L; Ozdogan H; Arisoy N Indian Pediatr; 2004 Oct; 41(10):1035-9. PubMed ID: 15523130 [TBL] [Abstract][Full Text] [Related]
12. Predictors of relapse in patients with oligoarticular juvenile idiopathic arthritis in remission off medication. Kaplan MM; Kurt T; Polat MC; Sezer M; Ekici Tekin Z; Çelikel E; Güngörer V; Tekgöz N; Karagöl C; Coşkun S; Öner N; Çelikel Acar B Eur J Pediatr; 2023 Oct; 182(10):4557-4564. PubMed ID: 37526705 [TBL] [Abstract][Full Text] [Related]
13. Elevated IgG autoantibody production in oligoarticular juvenile idiopathic arthritis may predict a refractory course. Stoll ML; Li QZ; Zhou J; Punaro M; Olsen NJ Clin Exp Rheumatol; 2011; 29(4):736-42. PubMed ID: 21813070 [TBL] [Abstract][Full Text] [Related]
14. Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register. Anink J; Otten MH; Prince FH; Hoppenreijs EP; Wulffraat NM; Swart JF; ten Cate R; van Rossum MA; van den Berg JM; Dolman KM; Koopman-Keemink Y; Armbrust W; Kamphuis S; van Pelt PA; Gorter SL; van Suijlekom-Smit LW Rheumatology (Oxford); 2013 Apr; 52(4):712-7. PubMed ID: 23267169 [TBL] [Abstract][Full Text] [Related]
15. Uveitis in juvenile arthritis. Berk AT; Koçak N; Unsal E Ocul Immunol Inflamm; 2001 Dec; 9(4):243-51. PubMed ID: 11935434 [TBL] [Abstract][Full Text] [Related]
16. Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany. Heiligenhaus A; Klotsche J; Niewerth M; Horneff G; Ganser G; Haas JP; Minden K Arthritis Res Ther; 2020 Apr; 22(1):81. PubMed ID: 32293540 [TBL] [Abstract][Full Text] [Related]
17. Risk markers of juvenile idiopathic arthritis-associated uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. Angeles-Han ST; Pelajo CF; Vogler LB; Rouster-Stevens K; Kennedy C; Ponder L; McCracken C; Lopez-Benitez J; Drews-Botsch C; Prahalad S; J Rheumatol; 2013 Dec; 40(12):2088-96. PubMed ID: 24187099 [TBL] [Abstract][Full Text] [Related]
18. Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis: Data From the Inception Cohort of Newly Diagnosed Patients With Juvenile Idiopathic Arthritis Study. Tappeiner C; Klotsche J; Sengler C; Niewerth M; Liedmann I; Walscheid K; Lavric M; Foell D; Minden K; Heiligenhaus A Arthritis Rheumatol; 2018 Oct; 70(10):1685-1694. PubMed ID: 29732713 [TBL] [Abstract][Full Text] [Related]
19. A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial). Ramanan AV; Dick AD; Benton D; Compeyrot-Lacassagne S; Dawoud D; Hardwick B; Hickey H; Hughes D; Jones A; Woo P; Edelsten C; Beresford MW; Trials; 2014 Jan; 15():14. PubMed ID: 24405833 [TBL] [Abstract][Full Text] [Related]
20. Frequency and Identification of Risk Factors of Uveitis in Juvenile Idiopathic Arthritis: A Long-term Follow-up Study in a Cohort of Italian Children. Conti G; Chirico V; Porcaro F; Fede C; Vitale A; Fede A; Castagna I; Fede C J Clin Rheumatol; 2020 Oct; 26(7):285-288. PubMed ID: 31609817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]